<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 10 Apr 2026 03:40:24 -0400--><rss version="2.0">
    <channel>
        <title>Vivani Medical, Inc. (VANI) In the News</title>
        <link>https://investors.vivani.com/investors/news-events/in-the-news/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_4126e3db6def33d543a652545d1b732f/vivanimedical/files/theme/images/logo-sm.png</url>
                <title>Vivani Medical, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[CEO Dr. Adam Mendelsohn and CBO Don Dwyer participated in a Vivani-hosted investor conference call to discuss recent progress in the LIBERATE-1 clinical trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://edge.media-server.com/mmc/p/2x6ivwcs/</link>
                <pubDate>Thu, 13 Mar 25 00:00:00 -0400</pubDate>
                <guid>https://edge.media-server.com/mmc/p/2x6ivwcs/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CEO Dr. Adam Mendelsohn presented at the Emerging Growth Conference on September 25, 2024.]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.youtube.com/EmergingGrowthConference</link>
                <pubDate>Wed, 25 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://www.youtube.com/EmergingGrowthConference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CEO Dr. Adam Mendelsohn joined Daniel Levine on the September 24, 2024 installment of The Bio Report podcast to discuss Vivani Medical’s implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.]]></title>
                <description><![CDATA[]]></description>
                <link>https://thebioreport.podbean.com/e/delivering-the-goods/</link>
                <pubDate>Tue, 24 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://thebioreport.podbean.com/e/delivering-the-goods/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CEO Dr. Adam Mendelsohn joined Alejandro Cremades’ DealMakers Podcast 2024]]></title>
                <description><![CDATA[]]></description>
                <link>https://alejandrocremades.com/he-raised-100-million-to-develop-a-portfolio-of-miniature-long-term-implants-to-deliver-drugs-more-efficiently-and-consistently/</link>
                <pubDate>Tue, 17 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://alejandrocremades.com/he-raised-100-million-to-develop-a-portfolio-of-miniature-long-term-implants-to-deliver-drugs-more-efficiently-and-consistently/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[H.C. Wainwright 26th Annual Global Investment Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://journey.ct.events/view/a00c80c3-0668-4058-b4ca-4aad48978600</link>
                <pubDate>Wed, 11 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://journey.ct.events/view/a00c80c3-0668-4058-b4ca-4aad48978600</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani’s CEO Adam Mendelsohn Presenting at the Benzinga Virtual Healthcare Summit on March 20, 2024]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.linkedin.com/posts/vivani-medical_vivani-medical-adam-mendelsohn-benzinga-activity-7178137324071886848-zuVd?utm_source=share&amp;amp;utm_medium=member_desktop</link>
                <pubDate>Wed, 20 Mar 24 00:00:00 -0400</pubDate>
                <guid>https://www.linkedin.com/posts/vivani-medical_vivani-medical-adam-mendelsohn-benzinga-activity-7178137324071886848-zuVd?utm_source=share&amp;amp;utm_medium=member_desktop</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Where one unicorn struggled, another biotech is aiming for a diabetes win]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.pharmavoice.com/news/Intarcia-Vivani-diabetes-implant/647151/</link>
                <pubDate>Mon, 10 Apr 23 00:00:00 -0400</pubDate>
                <guid>https://www.pharmavoice.com/news/Intarcia-Vivani-diabetes-implant/647151/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dr. Adam Mendelsohn Discusses Using Drug Implants to Reduce Burden of Medication Adherence on Empowered Patient Podcast with Karen Jagoda]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/in-the-news/detail/20813/dr-adam-mendelsohn-discusses-using-drug-implants-to-reduce</link>
                <pubDate>Wed, 08 Feb 23 00:00:00 -0500</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/in-the-news/detail/20813/dr-adam-mendelsohn-discusses-using-drug-implants-to-reduce</guid>
                                                                            </item>
            </channel>
</rss>